---

About the Speaker

Kevin Kubachka, PhD
SBRBPAS Expert (Chemist)
Forensic Chemistry Center
Office of Regulatory Affairs
U.S. Food and Drug Administration

About the Speaker

Dr. Kevin Kubachka is a chemist at the FDA’s Forensic Chemistry Center (FCC) where he has focused his efforts on elemental speciation and isotope ratio mass spectrometry.  He was instrumental in establishing FDA’s use of stable isotope ratio analysis, now a routinely used approach.  In addition to publishing and presenting his research, he has been an instructor and course organizer for several FDA analytical training courses.  

About the Presentation

Adding substances to high quality/price commodities for economic gain is a growing problem that is difficult to spot.  One tool the FDA uses is stable isotope ratio analysis, which has proved to be invaluable in detection of this adulteration.

Learning Objectives

1) Describe economic adulteration and how isotope ratio analysis is an important tool.
2) Explain how instrumentation used for isotopic ratio analysis operates.
3) Discuss applications for this analysis and share finding from completed work.

Events Materials

Activity Announcement
https://ceportal.fda.gov/index.cfm?do=cus.runEventReport&reportName=EventAnnouncementForm&style=2&preview=1&eventId=8544 

To Register

FDA employees MUST register in BOTH the following: 

• ZOOM REGSTRATION *Once you have registered in ZOOM, you will receive a confirmation email with the webcast URL
• LMS REGISTRATION  

Non-FDA employees must register in:  

• ZOOM REGSTRATION *Once you have registered in ZOOM, you will receive a confirmation email with the webcast URL

After Zoom webcast registration, you will receive a link via email to access the live webinar. You must log in with the username and password created when you registered.  Please pre-register at least two days before the event to ensure you receive the access link and outlook invitation for the session. We will discuss applications for this analysis and share finding from completed work.
For technical assistance please contact: Isaac.Miller@fda.hhs.gov